Device
Restylane® Lyft
Restylane® Lyft is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_4
1
25%
Ph phase_3
1
25%
Ph not_applicable
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Safety and Efficacy of Fillers for Contouring the Jawline
NCT06336759
completedphase_3
Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds
NCT04174131
completedphase_1
Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions
NCT04162002
completedphase_4
Midfacial Product Selection
NCT03381040
Clinical Trials (4)
Showing 4 of 4 trials
NCT06336759Not Applicable
Safety and Efficacy of Fillers for Contouring the Jawline
NCT04174131Phase 3
Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds
NCT04162002Phase 1
Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions
NCT03381040Phase 4
Midfacial Product Selection
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4